We investigated the haemodynamic and respiratory effects of propofol targetcontrolled infusion (TCI) during spontaneous ventilation. We studied 20 patients scheduled for elective orthopaedic surgery who were classified as American Society of Anesthesiologists physical status I. During spontaneous ventilation, haemodynamic, respiratory and electroencephalographic variables were measured. Oxygen flow was maintained at 5 l/min using a semi-closed system and a close-fitting face mask. All measurements were obtained before the propofol TCI and at each propofol effect-site concentration (0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5 and 4.0 µg/ml). Changes in Bispectral Index Score, systolic blood pressure, diastolic blood pressure, end tidal carbon dioxide tension and heart rate were negatively correlated with propofol effect-site concentrations. Despite maintaining oxygen saturation (≥ 99%), apnoea and blood pressure reductions were abruptly induced as the propofol effect-site concentration increased. We therefore recommend careful monitoring of haemodynamic and respiratory function during spontaneous ventilation using propofol TCI.
Introduction
Propofol is frequently the intravenous sedative/hypnotic of choice for diagnostic or minor procedures performed under local or regional anaesthesia. Favourable operating conditions and rapid recovery are the main advantages of propofol, but the disadvantages include a relatively high incidence of apnoea and blood pressure reductions. 1,2 A propofol target controlled infusion (TCI) is used for both conscious sedation and surgical anaesthesia, and the electroencephalogram (EEG) Bispectral Index Score (BIS) can be used to obtain an objective measure of the depth of anaesthesia.
Propofol has a depressant effect on metabolic ventilatory control, reducing the ventilatory response to hypoxia. 3 The peripheral carbon dioxide sensitivity is unaffected by propofol. 4 So far, the haemodynamic and respiratory changes caused by peripheral CO 2 sensitivity when using propofol TCI during spontaneous ventilation have not been studied.
We investigated the effects, with respect to safety, of propofol TCI on haemodynamic, respiratory and electroencephalographic changes during spontaneous ventilation. We maintained spontaneous ventilation, administered supplementary oxygen and prevented airway obstruction during the study.
Patients and methods

PATIENTS
The study population comprised patients scheduled for elective orthopaedic surgery who were aged between 18 and 60 years and classified as American Society of Anesthesiologists physical status I. Patients with known neurological, cardiac or metabolic disease, including those requiring anticonvulsant therapies and those taking cardiovascular medication, were excluded. The Human Studies Sub-committee approved the study and all patients gave written informed consent.
TREATMENT
Patients were pre-medicated with an intramuscular injection of 0.2 mg glycopyrrolate, 1 h before the operation. No pre-medication sedative was administered before surgery.
Propofol using a TCI system (Diprifusor ® , Master TCI, Vial Medical, Brezins, France) was administered at a target concentration of 4.5 µg/ml and 10 min induction mode during the study period. Fresh oxygen flow was constant at 5 l/min, from a semi-closed system via a face mask fitting closely over the mouth and nose. All patients continued to breathe spontaneously during anaesthesia.
MEASUREMENTS
The EEG recording was continuous (before and during propofol administration) using an Aspect A2000 BIS™ EEG monitor (Aspect Medical Systems, Natick, MA, USA) that also 
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Results
The demographic characteristics of the 20 patients in this study were: mean age ± SD, 32 ± 12.2 years; mean weight ± SD, 64 ± 8.6 kg; male:female ratio, 12:8.
Oxygen saturation did not change throughout the study (≥ 99%) and CO 2 rebreathing was minimal, as indicated by inspired CO 2 values ≤ 1 mmHg. No significant hypotension or bradycardia was 21 YS Lee Respiratory effects during propofol TCI FIGURE 1: Scatter diagrams of the relationship between three haemodynamic variables (A, systolic blood pressure; B, diastolic blood pressure; and C, heart rate) and the propofol effect-site concentration as measured in the patients with spontaneous respiration in this study. The number of patients decreased with increasing propofol effectsite concentration because of drop-out due to paradoxical respiration or apnoea: 0.5 -2.5 µg/ml propofol, n = 20; 3.0 µg/ml propofol, n = 17; 3.5 µg/ml propofol, n = 15; 4.0 µg/ml propofol, n = 9 The Pearson correlation co-efficients between the different variables and propofol effect-site concentration are shown in Table 1 .
TABLE 1: Pearson correlation co-efficients between haemodynamic, respiratory and electroencephalographic measurements and the propofol effect-site concentration in the patients in this study*
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Discussion
Sedation with propofol reduces anxiety levels and increases the patient's comfort during procedures performed under local or regional anaesthesia. It is often difficult, however, to predict haemodynamic and respiratory effects during spontaneous ventilation. TCI is designed to maintain the desired plasma or effect-site concentration of the drug by automatically adjusting the infusion rate according to a computer software calculation. 5 Nieuwenhuijs et al. 3 suggested that every patient given propofol anaesthesia should receive close monitoring, airway manipulation and assisted ventilation. Clinically, we administered oxygen, lifted the mandible and extended the neck as needed.
Bispectral Index Scores correlate with propofol concentration, 6 and Glass et al. 7 reported that BIS is another EEG-derived parameter that has been optimized to correlate with level of sedation and loss of consciousness. A blood propofol concentration of 4 µg/ml induces loss of consciousness in 90% of patients, 8, 9 so we measured all variables until the propofol effect-site concentration reached 4.0 µg/ml. Gajraj et al. 10 reported a mean BIS of 89.5 (± 4.6) during consciousness and 48.8 (± 16.4) during unconsciousness. We therefore considered propofol effect-site concentrations between 2.5 µg/ml and 3.0 µg/ml to represent the unconsciousness state. In addition, the propofol effect-site concentration was associated with BIS values indicative of a deep level of hypnosis.
Vasodilation and myocardial depression may cause a significant decrease in SBP, DBP and HR, and both myocardial depressant effects and vasodilation appear to be doseand plasma concentration-dependent. 11 Cullen et al. 12 determined that propofol resets rather than inhibits the baroreflex, thus reducing the tachycardic response to hypotension. A different study, however, reported that autonomic circulatory controls were relatively preserved until deeper levels (3.2 µg/ml target concentration) of sedation/hypnosis were achieved. 13 Oxygen saturation did not change during the study because of oxygen supplementation. In our study, pulse oximetry measured arterial oxygen saturation (not hypoventilation), which was directly reflected by an increase in carbon dioxide tension. In patients not breathing enriched oxygen mixtures, respiratory depression increases the risk of hypoxaemia. As pH decreases to < 7.2, cell homeostasis may be compromised because of an increase in arterial CO 2 tension (PaCO 2 ). 14 Values of ETCO 2 are commonly 2 -5 mmHg less than values of PaCO 2 ; this difference is attributed to dilution of alveolar gas by the gas in the physiological dead space (alveolar dead space plus anatomical dead space). Physiological dead space is linearly related to tidal volume during spontaneous ventilation. Undetected mask leaks are one possible source of inaccuracy. In addition, capnography during spontaneous ventilation is hampered by the difficulty in obtaining adequate sampling of alveolar air, mixing of inspired and expired gases and the occurrence of leaks in unintubated patients. 15 In our study there were significant decreases in ETCO 2 at ≥ 2.5 µg/ml compared with baseline, and RR did not change significantly. We did not measure PaCO 2 or tidal volume, so could not determine respiratory change.
Paradoxical respiration or apnoea was noted in our study at propofol effect-site concentrations ≥ 2.5 µg/ml and their incidence gradually increased with increasing concentration. ETCO 2 significantly decreased at propofol effect-site concentrations ≥ 2.5 µg/ml. Goodman et al. 1 reported that onset of apnoea is usually preceded by marked tidal volume YS Lee Respiratory effects during propofol TCI Copyright © 2004 Cambridge Medical Publications reduction and tachypnoea. We did not observe an increase in RR before apnoea. At a propofol effect-site concentration of 2.5 µg/ml, apnoea occurred in three patients (out of 20; 15%), but the rest continued to breathe spontaneously with 100% oxygen saturation, acceptable ETCO 2 values and a normal haemodynamic state. Paradoxical respiration or apnoea developed abruptly, accompanied by a marked ETCO 2 reduction.
In conclusion, we found that propofol TCI in spontaneously breathing patients is not without complications, despite maintaining oxygen saturation. In view of potential significant respiratory problems, haemodynamic and respiratory changes should be carefully monitored in all patients during propofol sedation.
